BLOG

Joint Surgery Alternatives: Adipose Stem Cell Therapy in Japan

7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

Chronic joint pain, often associated with conditions like osteoarthritis, can significantly impact daily activities and overall quality of life. While joint replacement surgery is a common and effective solution for severe cases, many individuals seek less invasive alternatives to postpone or avoid major surgery. Regenerative medicine offers promising avenues, and one such approach gaining attention is adipose-derived stem cell therapy, which utilizes the body’s own cells to manage symptoms and support tissue health.

A Non-Surgical Approach to Joint Pain Management

Adipose-derived stem cell therapy is an approach that uses your own mesenchymal stem cells (MSCs) harvested from fat tissue to help manage joint pain and inflammation. The primary goal is not to offer a definitive cure, but to create a better environment within the joint, potentially reducing pain and improving function. This treatment is considered a minimally invasive option, especially for those who are not yet ready for or wish to explore alternatives to surgery. The suitability of this therapy depends on an individual’s specific condition, and a thorough medical evaluation is essential.

Common Concerns for Those Facing Joint Surgery

If you’re dealing with persistent joint issues, you may be familiar with the following concerns:

  • Desire to Avoid Major Surgery: Many people are hesitant about the risks, long recovery times, and potential complications associated with procedures like total knee replacement.
  • Limitations of Current Treatments: Pain medications can have side effects with long-term use, and physical therapy may not provide sufficient relief for everyone.
  • Impact on Lifestyle: The goal is often to maintain an active lifestyle, and finding a treatment that supports this without extensive downtime is a priority.
  • Interest in Natural Healing: There is a growing interest in treatments that work with the body’s inherent ability to repair itself, rather than introducing artificial components.

These valid concerns drive many to research non-surgical joint pain relief options like regenerative medicine.

Understanding Adipose-Derived Stem Cell Therapy

This therapy is centered on mesenchymal stem cells (MSCs), which are known for their ability to support tissue repair and modulate inflammation. Here’s a simplified overview of the process:

  • What are MSCs? Mesenchymal stem cells are adult stem cells found in various tissues, including fat and bone marrow. They have been reported to secrete anti-inflammatory substances and growth factors that can help calm inflammation and support the repair of damaged tissues.
  • Why Use Fat Tissue? Fat (adipose) tissue is an abundant source of MSCs. Compared to bone marrow, fat tissue is considered to contain a higher concentration of these cells. The collection process is also less invasive, typically requiring only a small amount of tissue collected under local anesthesia.
  • The Treatment Process: A small sample of your fat tissue is collected. The MSCs are then isolated, cultured, and expanded in number at a specialized cell processing facility. Finally, the cultured cells are returned to your body, often through an intravenous (IV) infusion. Research suggests that infused MSCs can travel to sites of inflammation and injury in the body, a phenomenon known as the “homing effect.”

How Does It Compare to Surgical Options?

It’s important to understand that stem cell therapy and surgery are fundamentally different approaches. Joint replacement surgery involves removing the damaged joint surfaces and replacing them with an artificial implant. It is a structural solution for advanced joint degeneration.

In contrast, adipose-derived stem cell therapy is a biological approach. It does not replace any part of the joint. Instead, it aims to influence the joint’s environment by reducing inflammation and providing growth factors that may support the health of remaining cartilage and other tissues. It is a minimally invasive, outpatient procedure that leverages your body’s own cellular mechanisms. The outcomes can vary between individuals, and it is not considered a substitute for surgery in cases of severe structural damage but may be an option for managing symptoms at earlier stages.

What to Consider Before Treatment in Japan

If you are considering this therapy, several key points should be discussed with a qualified physician:

  • Medical Eligibility: This treatment is not suitable for everyone. A doctor will determine your eligibility based on a comprehensive examination, your medical history, and the specific condition of your joints.
  • Regulatory Framework: In Japan, regenerative medicine treatments like this are provided under the Act on the Safety of Regenerative Medicine. This means the treatment plan is reviewed and must meet national standards for safety management and cell processing.
  • Treatment Costs and Scope: This is a private medical treatment not covered by Japanese public health insurance. It’s essential to have a clear understanding of the costs, the number of recommended sessions, and the expected treatment period.
  • Potential Risks and Side Effects: While using your own cells (autologous) minimizes risks like rejection, potential side effects can include pain or infection at the fat collection site or reactions related to the infusion. All potential risks must be thoroughly explained by your doctor.

Discussing Your Options at Grand Green Osaka Umekita Clinic

For those in the Osaka area or visiting Japan, exploring advanced medical options is accessible. At Grand Green Osaka Umekita Clinic, we provide consultations for regenerative medicine, including adipose-derived stem cell therapy. Our approach is to help you understand all available options so you can make an informed decision that aligns with your health goals.

We believe patient education is paramount. To learn more about the specifics of this therapy, including the process, features, and other important considerations, we encourage you to review our detailed information page. A consultation with our physicians is the best way to determine if this non-surgical approach could be a suitable part of your joint health management plan.

For more details, please see our page on Adipose-Derived Stem Cell Therapy.

In summary, while surgery remains a vital tool for treating advanced joint disease, adipose-derived stem cell therapy represents a growing field in regenerative medicine that offers a minimally invasive alternative for managing symptoms. It is a personalized treatment that requires careful consideration and expert medical guidance. A direct consultation is the crucial first step to understanding if you are a potential candidate and what you can realistically expect.

References

Supervising Physician

Hidenori Shimada

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Grand Green Osaka South Building, Gate Tower 5F 5-54 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan

TEL: 06-7653-8493 FAX: 06-7635-8052

Contact